ObjectivesTo systematically review the training needs of managing staffs in tertiary hospitals in China, to understand the requirements of in-service training for hospital managing staffs, and to provide references for the target and content of tertiary hospital managing staff training.MethodsPubMed, EMbase, CNKI, WanFang Data and VIP databases were searched to collect cross-sectional studies on the training needs of managing staffs in tertiary hospitals in China. The retrieval time was from inception to July 29th, 2018. Two reviewers independently screened literature, extracted the data and descriptive analysis was conducted on the training needs of managing staffs in tertiary hospitals.ResultsA total of 11 studies were included. The results of systematic review suggested that: as for the requirements of training content, hospital management, leadership, personnel training, human resource management and innovation awareness were the most demanding training contents. As for the training methods, experience exchange, case study and topic teaching were the most popular. As for the training time, 2 to 3 days of quarterly training was the most acceptable training time.ConclusionsThere are great training requirements for managing staffs in tertiary hospitals in China, with a large amount of training content and diversity methods. In future, training objectives and methods should be designed to meet the requirements of managing staffs, so as to enhance training quality and achieve training goals.
Cadre education and training is the elementary step in building a high quality, basic, and strategic cadre ranks project. The summer training of cadres in West China Hospital of Sichuan University is one aspect of the training system of cadres in our hospital. This paper introduces the current situation of summer cadre training, the training needs of cadres and the changes of internal and external environment in our hospital from 2009 to 2012, so as to continue constructing our summer cadres training product brand.
Objective To observe and analysis the features of images of fundus fluorescein angriography (FFA) in low-perfused retinopathy caused by cephalo-cervical peripheral vascular stenosis or occlusion. Methods The results of FFA of 27 patients diagnosed with carotid artery stenosis or occlusion by digital subtraction angiography (DSA) and examination of Doppler and vascular-pulsation were retrospectively analyzed. Result All of the patients had a delayed arm-retinal circulation duration from 20.0 to 81.08 seconds with the mean of 32.1 seconds; a delayed retinal arteriovenous filling duration from 6 to 64.0 seconds with the mean of 24.2 seconds. Delayed arm-retinal circulation duration and retinal a rteriovenous filling duration in 10 cases (37.0%); microangioma, vascular wall staining, nonperfused capillary area in 11 (40.7%); and anterior ischemic syndrome in 6 (22.2%) were found. In the 6 patients with anterior ischemic syndrome, 4 cases had narrow retinal artery, segmental changes of blood stream, vascular atresia, and abnormal arterio-venous anastomosis, and 2 cases had bold vascular loops. Conclusions The main manifestations of FFA in patients with low-perfused retinopathy are malperfusion and retinal ischemia, whose degrees relate to the extend of carotid artery stenosis or atresia, and the process of the disease.Serious retinal ischemia may combined with anterior ischemic syndrome. (Chin J Ocul Fundus Dis，2004，20：84-86)
Rheumatoid arthritis is a chronic inflammatory disorder. It is characterized by a chronic polyarthritis that primarily affects the peripheral joints and related periarticular tissues. To a patient with rheumatoid arthritis, we searched the evidence and indentified the best available therapy for him: ① Ibuprofen was used to relieve pain. ② Methopterin ivgtt qw and oral methopterin after the discharge for 12 months. ③ Oral omeprazole 20 mg/d to prevent peptic ulcear. ④ Administration with fish oil and physical exercises after discharge were recommended.
Objectives To assess the efficacy and safety of cytidine diphosphate choline for patients with acute stroke. Methods Such databases as PubMed, The Cochrane Library, EMbase, Web of Science, CNKI, VIP Database and Chinese Medical Association Journals were searched from the establishment to September of 2010, and the references of the included literatures were also searched to collect randomized controlled trials (RCTs) of cytidine diphosphate choline for patients with acute stroke. The data were extracted by two reviewers independently in accordance with the inclusion criteria. The quality of included trials was evaluated according to the Jadad scale standard. RevMan5.0 software was used for data analyses. Results Thirteen RCTs involving 2837 patients were included. The results of meta-analyses showed that, there was no significant difference in the mortality or the rate of dependency at the end of follow-up (OR=0.94, 95%CI 0.66 to 1.36, P=0.75) between the cytidine diphosphate choline group and the placebo group. But the total effective rate of the cytidine diphosphate choline group was higher than that of the placebo group with a significant difference (OR=1.72, 95%CI 1.41 to 2.10, Plt;0.000 01). Five trials reported the incidence of adverse reaction of cytidine diphosphate choline treatment which showed the adverse reaction was mild; no severe adverse events (SAEs) were reported and the clinical application was safe. Conclusion The cytidine diphosphate choline is effective and safe for acute stroke. However, it is invalid to reduce the mortality and the rate of dependency at the end of three months’ follow-up.
Epilepsy is one of the most common neurological disorders, and status epilepticus (SE) can lead to permanent neuronal brain damage in the central nervous system, but the mechanism is not clear. Solving this problem will help to find more SE therapeutic targets, benefiting tens of millions of epilepsy patients. The pathway of SE leading to neuronal damage in the brain has made new progress in neuroinflammation, autophagy, apoptosis and pyroptosis, glial cell hyperplasia and category transformation, and changes in neurotransmitters in the brain, which will be beneficial to the discovery of new targets for the treatment of SE, thus laying a foundation for the development of new anti-epileptic drugs.
Objectives To survey the training needs of the management reserve talents in West China Hospital of Sichuan University, so as to provide evidence for improving the pertinence and effectiveness of the training system. Methods A survey of training needs in terms of training contents and methods was performed on 181 management reserve talents in our hospital by self-designed questionnaire. The survey results were descriptively analyzed based on rate and percentage. Results Among the 181 questionnaires issued, 148 (81.8%) were recovered. For the training contents, 59.5% of them concerned more about enhancement of management ability, with the top three most preferred training contents as personnel management, systematic management thinking, and work management. For the training methods, internal training, external communication, and external teachers were the three most preferred. Conclusions To enable the management reserve talents transit from medical to management positions, the hospital should classify them according to the needs and requirements of the organization, the position and the talent him/herself. Based on such classification, customized training can be carried out with innovative training modules.
【摘要】 目的 探討血漿胰蛋白酶原激活肽(trypsinogen activation peptide,TAP)水平與重癥急性胰腺炎(severe acute pancreatitis,SAP)胰腺壞死的關系。方法 2008年6月1日—2008年12月31日,采用ELISA法測定本院的35例SAP患者血漿TAP水平,并與胰腺增強CT掃描結果作對比,分析血漿TAP水平與胰腺壞死的關系,以及SAP無胰腺壞死組與SAP胰腺壞死組血漿TAP水平的差異。結果 入院時血漿TAP水平預測胰腺壞死的最佳截值點是10.43 nmol/mL,其敏感性、特異性、陽性預測值、陰性預測值分別為75%、73.9%、60%、15%,陽性比為2.87,陰性比為0.338。入院第1天血漿TAP水平預測胰腺壞死的最佳截值點是6.91 μmol/L,其敏感性、特異性、陽性預測值、陰性預測值分別為90.9%、65.2%、55.6%、6.3%,陽性似然比為2.61,陰性似然比為0.001。SAP胰腺壞死組入院時、入院第一天血漿TAP水平高于SAP無胰腺壞死組(Plt;0.05)。結論 血漿TAP水平變化與SAP病情變化密切相關,病程早期檢測血漿TAP水平有助于SAP患者胰腺壞死的預測
【摘要】 目的 評價生長抑素聯合中藥在治療重癥急性胰腺炎中的有效性。 方法 應用國際Cochrane協作網系統評價方法對生長抑素聯合中藥治療重癥急性胰腺炎的隨機對照試驗（RCT）進行系統評價。計算機檢索MEDLINE（Ovid）、PubMed數據庫、中文科技期全文數據庫（VIP）、萬方數據庫、中國期刊全文數據庫（CNKI）、中國生物醫學文獻數據庫（CBM）。檢索時間均為建庫至2009年9月。文獻檢索語種為英語和中文。 結果 共納入8個RCT，436例患者，所有納入試驗在治療末均未進行隨訪。Meta分析結果顯示，生長抑素聯合中藥治療組（治療組）的病死率（13/188，6.9%）明顯低于單純生長抑素治療組（對照組）（24/174，13.7%），差異有統計學意義[Peto OR=0.46，95%CI（0.22，0.94），Plt;0.05]。治療組平均住院日低于對照組[WMD=-7.01，95%CI（-7.89，-6.13），Plt;0.000 01]。治療組腹痛緩解時間明顯低于對照組，其差異有統計學意義[WMD=-0.77，95%CI（-0.82，-0.72），Plt;0.000 01]。治療組與對照組治療第7天APACHE Ⅱ評分均下降，治療組下降幅度大于對照組，兩組比較差異有統計學意義（Plt;0.05）。治療組并發癥發生率（26/91，28.6%）與對照組（35/88，39.8%）相比，其差異無統計學意義[Peto OR=0.61，95%CI（0.32，1.13），P=0.12]。 結論 生長抑素聯合中藥治療在改善重癥急性胰腺炎的病死率、平均住院時間、腹痛緩解時間、APACHE Ⅱ評分下降幅度優于單純生長抑素治療。
To systematically and retrospectively analyze Chinese exploration of novel coronavirus pneumonia, including emergency command, medical treatment, health and disease prevention, resource scheduling and other aspects, in order to provide references for the prevention and treatment of global infectious diseases.